ESMO: Moderna, BioNTech’s post-COVID futures in oncology hit manufacturing
ESMO: Moderna, BioNTech's post-COVID futures in oncology hit manufacturing realities FiercePharmaBioNTech's new CAR-T process boosts potency and side effects FierceBiotech5-Year Head & Neck Cancer Survival Increased From 45% to 73%…